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wTATE-OF-THE-ART PAPER1561Women and Ischemic Heart Diseaseeslee J. Shaw, Raffaelle Bugiardini, C. Noel Bairey Merz
haw and colleagues review the state of the art for treatment and evaluation of women with
schemic heart disease (IHD). Although women are less like to have obstructive coronary
rtery disease (CAD) and are more likely to have preserved systolic function, they have higher
hort-term mortality than men. This paradoxical difference appears to be linked to coronary
eactivity, especially microvascular dysfunction. Microvascular dysfunction may be more
revalent in women because of risk factor clustering and hormonal alterations. The authors
ropose that symptoms occurring due to coronary microvascular dysfunction that result in
yocardial ischemia should be called “microvascular angina” and that anti-anginal therapies
an improve symptoms, endothelial function, and quality of life; however, sex-specific trials
valuating adverse outcomes are needed.JACC WHITE PAPER ACC WHITE PAPER1576Reviewing the Data on Unprotected Left Main Stentingavid E. Kandzari, Antonio Colombo, Seung-Jung Park, Carl L. Tommaso, Stephen G. Ellis,
uis A. Guzman, Paul S. Teirstein, Corrado Tamburino, John Ormiston, Gregg W. Stone,
eorge D. Dangas, Jeffrey J. Popma, Theodore A. Bass, on behalf of the American College of Cardiology
nterventional Scientific Council
urrently, intersociety guidelines recommend against unprotected left main (UPLM)
ercutaneous revascularization as an optional therapy in individuals eligible for coronary artery
ypass grafting (Class III) and support the indication with still uncertain benefit (Class IIb)
nly in patients with excessive surgical risk. In this paper, Kandzari and colleagues argue that
he current guidelines are outdated, as several clinical trials and registries addressing this
ubject have recently been published. The authors review the currently published data and
onclude that even in patients without excessive surgical risk percutaneous revascularization
an be considered, especially if the anatomy is favorable, for example, isolated ostial or shaft
esions. The authors also lay out the many questions that will need to be answered before
idespread adoption of UPLM stenting can be considered.(continued on page A-24)
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EORONARY ARTERY DISEASE
1589train Imaging Detects Prolonged Impairment
of Diastolic Function After Transient IschemiaAVC 1/3 DD
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Aatsuhisa Ishii, Tamaki Suyama, Makoto Imai, Motoyoshi Maenaka, Asuka Yamanaka, Yasunaka Makino,
utaka Seino, Kenei Shimada, Junichi Yoshikawa
shii and colleagues studied whether strain imaging (SI), which measures the extent of
egional myocardial shortening and lengthening, could detect ischemia-induced alterations in
iastolic and systolic function. Regional left ventricular transverse peak strain and strain
hanges during the first one-third of diastole (strain imaging diastolic index [SI-DI]) were
easured in “at-risk” segments after temporary balloon occlusion in 30 patients undergoing
ercutaneous coronary intervention. Coronary occlusion induced a marked regional reduction
n both systolic strain and SI-DI. Upon reperfusion, systolic strain parameters returned to
re-occlusion values quickly. However, SI-DI remained depressed for up to 24 h after
eperfusion. SI analysis provides detailed mechanical characterization of regions with
yocardial insult and can demonstrate post-ischemic diastolic stunning despite completeystolic functional recovery.IOMARKERS AND CARDIAC SURGERY1599BNP Level May Improve Pre-Operative Risk Assessment CMEanesan Karthikeyan, Ross A. Moncur, Oren Levine, Diane Heels-Ansdell, Matthew T. V. Chan,
ablo Alonso-Coello, Salim Yusuf, Daniel Sessler, Juan Carlos Villar, Otavio Berwanger, Matthew McQueen,
nna Mathew, Stephen Hill, Simon Gibson, Colin Berry, Huei-Ming Yeh, P. J. Devereaux
arthikeyan and colleagues conducted a systematic review and meta-analysis to determine if
re-operatively measuring brain natriuretic peptide (BNP) (or N-terminal proBNP)
ndependently predicts 30-day adverse cardiovascular outcomes after noncardiac surgery. Nine
tudies met eligibility criteria and included over 3,000 subjects and over 300 perioperative
ardiovascular complications. The average proportion of patients with elevated BNP was 25,
ut the threshold for elevation varied in the different studies. All studies showed a statistically
ignificant association between an elevated pre-operative BNP and various cardiovascular
utcomes (e.g., a composite of cardiac death and nonfatal myocardial infarction, atrial
brillation). These results suggest that physicians can use a pre-operative BNP measurement
o substantially improve their perioperative cardiovascular risk predictions, but more research
s required to determine appropriate thresholds in various patient categories.
ditorial Comment: Daniel Bolliger, Manfred D. Seeberger, Miodrag Filipovic, p. 1607(continued on page A-25)
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EENETICS AND STATIN EFFECTS1609Genetic Variant Associated With Risk of Statin-Induced Myalgiaseepak Voora, Svati H. Shah, Ivan Spasojevic, Shazia Ali, Carol R. Reed, Benjamin A. Salisbury,
eoffrey S. Ginsburg
oora and colleagues sought to identify single nucleotide polymorphisms (SNPs) that are
ssociated with mild statin-induced side effects such as myalgias. Subjects in the
TRENGTH (Statin Response Examined by Genetic Haplotype Markers) study were
andomized to both low and high doses of various statins. The primary end point was a
omposite adverse event (CAE), defined as discontinuation for any side effect, myalgia, or
reatine kinase 3 baseline. SNPs associated with reduced function in 5 genes of the
ytochrome P450 system were identified. CAEs occurred in 20% of subjects and were more
revalent in women and in carriers of the SLCO1B1*5 variant. There was evidence for a
ene-dose effect with SLCO1B1*5, further confirming this finding. This variant allele has
reviously been found to interfere with localization of the hepatic drug transporter to the
lasma membrane, and these data associate this SNP with even mild adverse effects induced
y statin therapy.ditorial Comment: Joseph S. Rossi, Howard L. McLeod, p. 1617PRE-CLINICAL RESEARCH RE-CLINICAL RESEARCH1619PET Imaging Can Quantify Efficacy of Cardiac Stem Cell Transplantationohn Terrovitis, Riikka Lautamäki, Michael Bonios, James Fox, James M. Engles, Jianhua Yu,
ichelle K. Leppo, Martin G. Pomper, Richard L. Wahl, Jurgen Seidel, Benjamin M. Tsui,
rank M. Bengel, M. Roselle Abraham, Eduardo Marba´n
errovitis and colleagues describe their use of positron emission tomography (PET) to
uantify retention of cardiac-derived stem cells (CDCs) and to evaluate different delivery
ethods. CDCs derived from male rats were labeled with [18F]-fluoro-deoxy-glucose
18FDG) and injected into the ischemic region of female rats following permanent left
oronary artery ligation. 18FDG PET imaging was then compared with quantitative
olymerase chain reaction (PCR) for the male-specific SRY gene. Baseline myocardial
etention of cells 1 h after delivery was 18% by PCR and 18% by PET. The efficacy of
arious interventions was also measured: 76% if given immediately after coronary occlusion,
5% when given with adenosine to slow the heart rate, and 37% when fibrin glue was used to
old the cells in place. In vivo PET imaging permits accurate measurement of CDC
etention and will allow for comparison of techniques to improve engraftment in beating
earts.ditorial Comment: Gary S. Feigenbaum, Louis Lemberg, Joshua M. Hare, p. 1627
